These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33311014)

  • 41. Progenitor cells and vascular function are impaired in patients with chronic kidney disease.
    Jie KE; Zaikova MA; Bergevoet MW; Westerweel PE; Rastmanesh M; Blankestijn PJ; Boer WH; Braam B; Verhaar MC
    Nephrol Dial Transplant; 2010 Jun; 25(6):1875-82. PubMed ID: 20083473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of microvascular endothelial function in type 1 diabetes using laser speckle contrast imaging.
    de M Matheus AS; Clemente EL; de Lourdes Guimarães Rodrigues M; Torres Valença DC; Gomes MB
    J Diabetes Complications; 2017 Apr; 31(4):753-757. PubMed ID: 28089343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thyroid function and cardiovascular events in chronic kidney disease patients.
    Afsar B; Yilmaz MI; Siriopol D; Unal HU; Saglam M; Karaman M; Gezer M; Sonmez A; Eyileten T; Aydin I; Hamcan S; Oguz Y; Covic A; Kanbay M
    J Nephrol; 2017 Apr; 30(2):235-242. PubMed ID: 27039198
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced Microvascular Density in Omental Biopsies of Children with Chronic Kidney Disease.
    Burkhardt D; Bartosova M; Schaefer B; Grabe N; Lahrmann B; Nasser H; Freise C; Schneider A; Lingnau A; Degenhardt P; Ranchin B; Sallay P; Cerkauskiene R; Malina M; Ariceta G; Schmitt CP; Querfeld U
    PLoS One; 2016; 11(11):e0166050. PubMed ID: 27846250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endothelial function and cardiovascular events in chronic kidney disease.
    Hirata Y; Sugiyama S; Yamamoto E; Matsuzawa Y; Akiyama E; Kusaka H; Fujisue K; Kurokawa H; Matsubara J; Sugamura K; Maeda H; Iwashita S; Jinnouchi H; Matsui K; Ogawa H
    Int J Cardiol; 2014 May; 173(3):481-6. PubMed ID: 24703800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endothelial dysfunction correlates with exaggerated exercise pressor response during whole body maximal exercise in chronic kidney disease.
    Downey RM; Liao P; Millson EC; Quyyumi AA; Sher S; Park J
    Am J Physiol Renal Physiol; 2017 May; 312(5):F917-F924. PubMed ID: 28274927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carbamylated low-density lipoprotein induces endothelial dysfunction.
    Speer T; Owala FO; Holy EW; Zewinger S; Frenzel FL; Stähli BE; Razavi M; Triem S; Cvija H; Rohrer L; Seiler S; Heine GH; Jankowski V; Jankowski J; Camici GG; Akhmedov A; Fliser D; Lüscher TF; Tanner FC
    Eur Heart J; 2014 Nov; 35(43):3021-32. PubMed ID: 24658767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of endothelial dysfunction in Asian Indian patients with chronic kidney disease and changes following renal transplantation.
    Sharma J; Kapoor A; Muthu R; Prasad N; Sinha A; Khanna R; Kumar S; Garg N; Tewari S; Sharma RK; Goel P
    Clin Transplant; 2014 Aug; 28(8):889-96. PubMed ID: 24930933
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Statins and antiplatelet agents are associated with changes in the circulatory markers of endothelial dysfunction in chronic kidney disease.
    García-Menéndez E; Marques Vidas M; Alique M; Carracedo J; de Sequera P; Corchete E; Pérez García R; Ramírez Chamond R; Portolés Pérez JM
    Nefrologia (Engl Ed); 2019; 39(3):287-293. PubMed ID: 30732927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Methylarginies-induced endothelial dysfunction in chronic kidney disease].
    Kimura K
    Yakugaku Zasshi; 2012; 132(4):443-8. PubMed ID: 22465920
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Leptin promotes endothelial dysfunction in chronic kidney disease through AKT/GSK3β and β-catenin signals.
    Ding N; Liu B; Song J; Bao S; Zhen J; Lv Z; Wang R
    Biochem Biophys Res Commun; 2016 Nov; 480(4):544-551. PubMed ID: 27789284
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of laser Doppler flowmetry tests, serum angiopoietin-2, asymmetric and symmetric dimethylarginine to predict outcome in chronic kidney disease.
    Nemcsik J; Cseprekál O; Egresits J; Kielstein J; Kümpers P; Lukasz A; Tabák Á; Marton A; Németh ZK; Járai Z; Godina G; Sallai L; Farkas K; Kiss I; Tislér A
    J Hypertens; 2017 May; 35(5):1109-1118. PubMed ID: 28106663
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-invasive assessment of microvascular and endothelial function.
    Cheng C; Daskalakis C; Falkner B
    J Vis Exp; 2013 Jan; (71):e50008. PubMed ID: 23407262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microvascular abnormalities in adjuvant-induced arthritis: relationship to macrovascular endothelial function and markers of endothelial activation.
    Totoson P; Maguin-Gaté K; Nappey M; Prati C; Wendling D; Demougeot C
    Arthritis Rheumatol; 2015 May; 67(5):1203-13. PubMed ID: 25708190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coronary Microvascular Endothelial Dysfunction in Patients With Angina and Nonobstructive Coronary Artery Disease Is Associated With Elevated Serum Homocysteine Levels.
    Ahmad A; Corban MT; Toya T; Sara JD; Lerman B; Park JY; Lerman LO; Lerman A
    J Am Heart Assoc; 2020 Oct; 9(19):e017746. PubMed ID: 32993421
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of Markers of Microvascular Dysfunction With Prevalent and Incident Depressive Symptoms: The Maastricht Study.
    Geraets AFJ; van Agtmaal MJM; Stehouwer CDA; Sörensen BM; Berendschot TTJM; Webers CAB; Schaper NC; Henry RMA; van der Kallen CJH; Eussen SJPM; Koster A; van Sloten TT; Köhler S; Schram MT; Houben AJHM
    Hypertension; 2020 Aug; 76(2):342-349. PubMed ID: 32639880
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rationale and design of an investigator-initiated, multicenter, prospective open-label, randomized trial to evaluate the effect of ipragliflozin on endothelial dysfunction in type 2 diabetes and chronic kidney disease: the PROCEED trial.
    Tanaka A; Shimabukuro M; Okada Y; Sugimoto K; Kurozumi A; Torimoto K; Hirai H; Node K;
    Cardiovasc Diabetol; 2020 Jun; 19(1):85. PubMed ID: 32534578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characteristics of coronary artery disease in chronic kidney disease.
    Fujii H; Kono K; Nishi S
    Clin Exp Nephrol; 2019 Jun; 23(6):725-732. PubMed ID: 30830548
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endothelial dysfunction as an underlying pathophysiological condition of chronic kidney disease.
    Satoh M
    Clin Exp Nephrol; 2012 Aug; 16(4):518-21. PubMed ID: 22669535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanism of endothelial dysfunction in chronic kidney disease.
    Malyszko J
    Clin Chim Acta; 2010 Oct; 411(19-20):1412-20. PubMed ID: 20598675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.